Ophthalmic devices include vision care products and surgery devices for the diagnosis and treatment of eye diseases. Risk of eye related diseases or retinal disorders such as vision defects (refraction), cataracts, and glaucoma, increase with age and can be chronic in several cases. Increasing prevalence of eye related disorders such as cataract, glaucoma, and blindness is expected to drive growth of the ophthalmic devices market. For instance, according to The International Agency for the Prevention of Blindness (IAPB), in 2015; 253 million people were blind or vision impaired, worldwide.  

Moreover, increasing prevalence of eye disorders in geriatric population and changing food habits leading to nutritional deficits in younger population are resulting in increasing adoption of ophthalmic devices. For instance, according to the International Journal of Advanced Medical and Health Research 2015, cataract is a major cause of blindness, affecting 17-18 million people worldwide, accounting for 39% of such cases.

Technological advancements in ophthalmic devices and increasing initiatives by government  and healthcare regulatory bodies to ensure establishment of sophisticated healthcare infrastructure and better eye safety and vision care is are expected to propel growth of the ophthalmic devices market. American Academy of Ophthalmology: a global association of eye physicians and surgeons, each month; engaged in raising awareness regarding eye health among the global population.                           

Market Dynamics

Governments in emerging economies are focused on establishing sophisticated healthcare infrastructure and eye care centers. This is owing to increasing demand for treatment related to eye disorders such as cataract, glaucoma, and macular degeneration. This is turn is expected to boost growth of the global ophthalmic devices market.

For instance, Directorate General of Health Services: Government of India launched a National Program for Control of Blindness and Visual Impairment (NPCB&VI) in 1976 with the goal of reducing the prevalence of blindness to 0.3% by 2020. A current survey in progress (2015-18) shows projected rate of prevalence of blindness is 0.45%. Government of India is focused on lowering this rate to 0.3% by 2020.

In February 1999, the World Health Organization (WHO), together with over 20 international non-governmental organizations involved in eye care and prevention and management of blindness, launched VISION 2020, a global initiative that aims to eliminate avoidable blindness by 2020.     

Key features of the study

• This report provides in-depth analysis of ophthalmic devices market, its market size (USD Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025, as the base year.
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global ophthalmic devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies.
• Key companies covered as a part of this study include, Carl Zeiss Meditec Group, Escalon Medical Corp., Haag-Streit AG, Heidelberg Engineering GmbH, Heine Optotechnik GmbH & Co. KG, Essilor International S.A., NIDEK CO., LTD., Quantel Medical SAS, Luneau Technology Group, and Topcon Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future type up-gradation, market expansion, and marketing tactics.
• The global ophthalmic devices market report caters to various stakeholders in this industry including investors, researchers, ophthalmic devices manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the ophthalmic devices market.

 Market Segmentation

• By Product Type (Revenue, USD Mn, 2021-2033)
  • Vision Care Devices
  • Surgery Devices
  • Diagnostic and Monitoring Devices
• By End User (Revenue, USD Mn, 2021-2033)
  • Hospitals
  • Ophthalmic Clinics and Centers
  • Ambulatory Surgical Centers
• By Region (Revenue, USD Mn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
• Key Players
  • Carl Zeiss Meditec AG
  • Escalon Medical Corp.
  • Haag-Streit AG
  • Heidelberg Engineering GmbH
  • Heine Optotechnik GmbH & Co. KG
  • Essilor International S.A.
  • NIDEK CO., LTD.
  • Quantel Medical SAS
  • Luneau Technology Group
  • Topcon Corporation